On Thursday, Takeda Pharmaceutical Co. (NYSE:TAK) announced that its board of directors had selected Julie Kim, president of Takeda’s U.S. business unit, as Weber’s successor. The life ...

January 30, 2025--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U ...

Takeda Pharmaceutical 4502-0.74%decrease; red down pointing triangle named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. The company called the ...

Kim isn't just a humour merchant. She's also a Canadian Screen Award-winning writer and producer who worked with Simu Liu ...

Does Warren Buffett Know Something Wall Street Doesn't? He's Done This 1 Thing for the First Time in 30 Years, and It May Be a Warning for Investors. Satya Nadella Said 'We Should Take Development ...